|
⚲
|
| Keyboard |
| Karen Hong | |
|---|---|
| Firm | |
| Address | Stridebio, Inc 5 Laboratory Drive, Suite 1200 Durham, NC 27709 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Stridebio Inc | 021-393667 | Director | 48.9 M of 81.5 M |
||
| Cyteir Therapeutics Inc | 021-389697 | Director | 80.0 M | ||
| Cyteir Therapeutics Inc | 021-350987 | Director | 20.2 M | ||
| Obsidian Therapeutics Inc | 021-300326 | Director | 32.4 M of 49.9 M |
||
| Palleon Pharmaceuticals Inc | 021-266476 | Director | 20.6 M of 48.3 M |
||
| Agile Therapeutics Inc | 021-233635 | Director | 20.0 M of 20.0 M |
||
| Agile Therapeutics Inc | 021-217112 | Director | 3.0 M of 3.0 M |
||
| Mersana Therapeutics Inc | 021-182471 | Director | 12.5 M of 27.0 M |
||
| Agile Therapeutics Inc | 021-182009 | Director | 23.7 M of 40.7 M |
||
| Agile Therapeutics Inc | 021-143050 | Director | 33.1 M of 45.1 M |
||
| Agile Therapeutics Inc | 021-141527 | Director | 1.0 M of 1.5 M |
||
| Agile Therapeutics Inc | 021-58185 | Director | 1.0 M of 2.0 M |
||